↓ Skip to main content

Metabolomics – the complementary field in systems biology: a review on obesity and type 2 diabetes

Overview of attention for article published in Molecular BioSystems, January 2015
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

twitter
3 X users
facebook
1 Facebook page

Citations

dimensions_citation
96 Dimensions

Readers on

mendeley
187 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Metabolomics – the complementary field in systems biology: a review on obesity and type 2 diabetes
Published in
Molecular BioSystems, January 2015
DOI 10.1039/c5mb00158g
Pubmed ID
Authors

Mohamad Hafizi Abu Bakar, Mohamad Roji Sarmidi, Kian-Kai Cheng, Abid Ali Khan, Chua Lee Suan, Hasniza Zaman Huri, Harisun Yaakob

Abstract

Metabolomic studies on obesity and type 2 diabetes mellitus have led to a number of mechanistic insights into biomarker discovery and comprehension of disease progression at metabolic levels. This article reviews a series of metabolomic studies carried out in previous and recent years on obesity and type 2 diabetes, which have shown potential metabolic biomarkers for further evaluation of the diseases. Literature including journals and books from Web of Science, Pubmed and related databases reporting on the metabolomics in these particular disorders are reviewed. We herein discuss the potential of reported metabolic biomarkers for a novel understanding of disease processes. These biomarkers include fatty acids, TCA cycle intermediates, carbohydrates, amino acids, choline and bile acids. The biological activities and aetiological pathways of metabolites of interest in driving these intricate processes are explained. The data from various publications supported metabolomics as an effective strategy in the identification of novel biomarkers for obesity and type 2 diabetes. Accelerating interest in the perspective of metabolomics to complement other fields in systems biology towards the in-depth understanding of the molecular mechanisms underlying the diseases is also well appreciated. In conclusion, metabolomics can be used as one of the alternative approaches in biomarker discovery and the novel understanding of pathophysiological mechanisms in obesity and type 2 diabetes. It can be foreseen that there will be an increasing research interest to combine metabolomics with other omics platforms towards the establishment of detailed mechanistic evidence associated with the disease processes.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 187 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 2 1%
Malaysia 1 <1%
Netherlands 1 <1%
France 1 <1%
Spain 1 <1%
United States 1 <1%
Luxembourg 1 <1%
Unknown 179 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 38 20%
Student > Ph. D. Student 32 17%
Student > Master 28 15%
Student > Doctoral Student 14 7%
Student > Bachelor 13 7%
Other 28 15%
Unknown 34 18%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 40 21%
Agricultural and Biological Sciences 35 19%
Medicine and Dentistry 26 14%
Chemistry 15 8%
Pharmacology, Toxicology and Pharmaceutical Science 7 4%
Other 22 12%
Unknown 42 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 March 2016.
All research outputs
#15,422,552
of 25,756,911 outputs
Outputs from Molecular BioSystems
#861
of 1,773 outputs
Outputs of similar age
#188,210
of 361,654 outputs
Outputs of similar age from Molecular BioSystems
#71
of 234 outputs
Altmetric has tracked 25,756,911 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,773 research outputs from this source. They receive a mean Attention Score of 3.8. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 361,654 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 234 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.